Calamos Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
VCM
VPM
Calamos Advisors's MDT Position: Q1 2026 in Review
Calamos Advisors increased its Medtronic (MDT) stake by 4.3% in Q1 2026, buying an estimated $2.41M and bringing the position to 602,965 shares worth $52.2M. The position accounts for 0.19% of the portfolio, ranked #123.
Calamos Advisors first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $113M in Q2 2019. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Calamos Advisors held 602,965 shares of Medtronic worth $52.2M as of Q1 2026.
- Calamos Advisors bought 25,128 Medtronic shares in Q1 2026, an estimated $2.41M.
- Medtronic made up 0.19% of Calamos Advisors's portfolio in Q1 2026, its #123 holding.
- Calamos Advisors first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
- Calamos Advisors's Medtronic position peaked at $113M in Q2 2019.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Calamos Advisors's 13F filing for Q1 2026, filed 4 May 2026.